 | • レポートコード：QYR2104Z1701 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、嚢胞様黄斑浮腫（CME）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗血管内皮増殖因子（VEGF）剤、炭酸脱水酵素阻害剤、ステロイド）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・嚢胞様黄斑浮腫（CME）の市場動向 ・企業の競争状況、市場シェア ・嚢胞様黄斑浮腫（CME）の種類別市場規模（非ステロイド性抗炎症薬、抗血管内皮増殖因子（VEGF）剤、炭酸脱水酵素阻害剤、ステロイド） ・嚢胞様黄斑浮腫（CME）の用途別市場規模（病院、外来手術センター、その他） ・嚢胞様黄斑浮腫（CME）の北米市場規模2016-2027（アメリカ、カナダ） ・嚢胞様黄斑浮腫（CME）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・嚢胞様黄斑浮腫（CME）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・嚢胞様黄斑浮腫（CME）の中南米市場規模2016-2027（メキシコ、ブラジル） ・嚢胞様黄斑浮腫（CME）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（EMMES、Fovea Pharmaceuticals、Icon Bioscience、Merck、Sanwa Kagaku Kenkyusho、Novartis、Johns Hopkins University、Wake Forest University、Iladevi Cataract、IOL Research Center、Rabin Medical Center、Kyushu University、Wills Eye Institute） ・結論 |
Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disruption of the normal blood-retinal barrier which leads to leakage from the perifoveal retinal capillaries causing accumulation of fluid within the intracellular spaces of the retina, mainly in the outer plexiform layer. CME is of two types: pseudophakic and nonpseudophakic cystoid macular edema. Pseudophakic cystoids macular edema is when the cause of occurrence is known while nonpseudophakic is the condition where no specific clinical findings have been observed. Symptoms of cystoids macular edema are blurred or decreased central vision.
The cause of CME is not completely known though it may be accompanied by various diseases such as uveitis, vein occlusion or diabetes. It is also known to occur commonly after cataract surgery. Various risk factors associated with cystoids macular edema are penetrating keratoplasty (corneal transplant), retinal surgery, chronic renal failure, retinal vein occlusion, retinitis pigmentosa, systemic medication and topical prostaglandin analogs for glaucoma..No significant racial or sex related predilection exists for this condition. However, cystoids macular edema can occur at any age based on the etiology, though advanced age is at higher risk.
Market Analysis and Insights: Global Cystoid Macular Edema Market
The global Cystoid Macular Edema market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cystoid Macular Edema market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cystoid Macular Edema market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cystoid Macular Edema market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cystoid Macular Edema market.
Global Cystoid Macular Edema Scope and Market Size
Cystoid Macular Edema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cystoid Macular Edema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non Steroidal Anti-Inflammatory Drugs
Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Carbonic Anhydrase Inhibitors
Steroids
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
EMMES
Fovea Pharmaceuticals
Icon Bioscience
Merck
Sanwa Kagaku Kenkyusho
Novartis
Johns Hopkins University
Wake Forest University
Iladevi Cataract
Merck
Sanwa Kagaku Kenkyusho
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cystoid Macular Edema Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non Steroidal Anti-Inflammatory Drugs
1.2.3 Anti- Vascular Endothelial Growth Factor (VEGF) Agents
1.2.4 Carbonic Anhydrase Inhibitors
1.2.5 Steroids
1.3 Market by Application
1.3.1 Global Cystoid Macular Edema Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cystoid Macular Edema Market Perspective (2016-2027)
2.2 Cystoid Macular Edema Growth Trends by Regions
2.2.1 Cystoid Macular Edema Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cystoid Macular Edema Historic Market Share by Regions (2016-2021)
2.2.3 Cystoid Macular Edema Forecasted Market Size by Regions (2022-2027)
2.3 Cystoid Macular Edema Industry Dynamic
2.3.1 Cystoid Macular Edema Market Trends
2.3.2 Cystoid Macular Edema Market Drivers
2.3.3 Cystoid Macular Edema Market Challenges
2.3.4 Cystoid Macular Edema Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cystoid Macular Edema Players by Revenue
3.1.1 Global Top Cystoid Macular Edema Players by Revenue (2016-2021)
3.1.2 Global Cystoid Macular Edema Revenue Market Share by Players (2016-2021)
3.2 Global Cystoid Macular Edema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cystoid Macular Edema Revenue
3.4 Global Cystoid Macular Edema Market Concentration Ratio
3.4.1 Global Cystoid Macular Edema Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cystoid Macular Edema Revenue in 2020
3.5 Cystoid Macular Edema Key Players Head office and Area Served
3.6 Key Players Cystoid Macular Edema Product Solution and Service
3.7 Date of Enter into Cystoid Macular Edema Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cystoid Macular Edema Breakdown Data by Type
4.1 Global Cystoid Macular Edema Historic Market Size by Type (2016-2021)
4.2 Global Cystoid Macular Edema Forecasted Market Size by Type (2022-2027)
5 Cystoid Macular Edema Breakdown Data by Application
5.1 Global Cystoid Macular Edema Historic Market Size by Application (2016-2021)
5.2 Global Cystoid Macular Edema Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cystoid Macular Edema Market Size (2016-2027)
6.2 North America Cystoid Macular Edema Market Size by Type
6.2.1 North America Cystoid Macular Edema Market Size by Type (2016-2021)
6.2.2 North America Cystoid Macular Edema Market Size by Type (2022-2027)
6.2.3 North America Cystoid Macular Edema Market Size by Type (2016-2027)
6.3 North America Cystoid Macular Edema Market Size by Application
6.3.1 North America Cystoid Macular Edema Market Size by Application (2016-2021)
6.3.2 North America Cystoid Macular Edema Market Size by Application (2022-2027)
6.3.3 North America Cystoid Macular Edema Market Size by Application (2016-2027)
6.4 North America Cystoid Macular Edema Market Size by Country
6.4.1 North America Cystoid Macular Edema Market Size by Country (2016-2021)
6.4.2 North America Cystoid Macular Edema Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cystoid Macular Edema Market Size (2016-2027)
7.2 Europe Cystoid Macular Edema Market Size by Type
7.2.1 Europe Cystoid Macular Edema Market Size by Type (2016-2021)
7.2.2 Europe Cystoid Macular Edema Market Size by Type (2022-2027)
7.2.3 Europe Cystoid Macular Edema Market Size by Type (2016-2027)
7.3 Europe Cystoid Macular Edema Market Size by Application
7.3.1 Europe Cystoid Macular Edema Market Size by Application (2016-2021)
7.3.2 Europe Cystoid Macular Edema Market Size by Application (2022-2027)
7.3.3 Europe Cystoid Macular Edema Market Size by Application (2016-2027)
7.4 Europe Cystoid Macular Edema Market Size by Country
7.4.1 Europe Cystoid Macular Edema Market Size by Country (2016-2021)
7.4.2 Europe Cystoid Macular Edema Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cystoid Macular Edema Market Size (2016-2027)
8.2 Asia-Pacific Cystoid Macular Edema Market Size by Type
8.2.1 Asia-Pacific Cystoid Macular Edema Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cystoid Macular Edema Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cystoid Macular Edema Market Size by Type (2016-2027)
8.3 Asia-Pacific Cystoid Macular Edema Market Size by Application
8.3.1 Asia-Pacific Cystoid Macular Edema Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cystoid Macular Edema Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cystoid Macular Edema Market Size by Application (2016-2027)
8.4 Asia-Pacific Cystoid Macular Edema Market Size by Region
8.4.1 Asia-Pacific Cystoid Macular Edema Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cystoid Macular Edema Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cystoid Macular Edema Market Size (2016-2027)
9.2 Latin America Cystoid Macular Edema Market Size by Type
9.2.1 Latin America Cystoid Macular Edema Market Size by Type (2016-2021)
9.2.2 Latin America Cystoid Macular Edema Market Size by Type (2022-2027)
9.2.3 Latin America Cystoid Macular Edema Market Size by Type (2016-2027)
9.3 Latin America Cystoid Macular Edema Market Size by Application
9.3.1 Latin America Cystoid Macular Edema Market Size by Application (2016-2021)
9.3.2 Latin America Cystoid Macular Edema Market Size by Application (2022-2027)
9.3.3 Latin America Cystoid Macular Edema Market Size by Application (2016-2027)
9.4 Latin America Cystoid Macular Edema Market Size by Country
9.4.1 Latin America Cystoid Macular Edema Market Size by Country (2016-2021)
9.4.2 Latin America Cystoid Macular Edema Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cystoid Macular Edema Market Size (2016-2027)
10.2 Middle East & Africa Cystoid Macular Edema Market Size by Type
10.2.1 Middle East & Africa Cystoid Macular Edema Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cystoid Macular Edema Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cystoid Macular Edema Market Size by Type (2016-2027)
10.3 Middle East & Africa Cystoid Macular Edema Market Size by Application
10.3.1 Middle East & Africa Cystoid Macular Edema Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cystoid Macular Edema Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cystoid Macular Edema Market Size by Application (2016-2027)
10.4 Middle East & Africa Cystoid Macular Edema Market Size by Country
10.4.1 Middle East & Africa Cystoid Macular Edema Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cystoid Macular Edema Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 EMMES
11.1.1 EMMES Company Details
11.1.2 EMMES Business Overview
11.1.3 EMMES Cystoid Macular Edema Introduction
11.1.4 EMMES Revenue in Cystoid Macular Edema Business (2016-2021)
11.1.5 EMMES Recent Development
11.2 Fovea Pharmaceuticals
11.2.1 Fovea Pharmaceuticals Company Details
11.2.2 Fovea Pharmaceuticals Business Overview
11.2.3 Fovea Pharmaceuticals Cystoid Macular Edema Introduction
11.2.4 Fovea Pharmaceuticals Revenue in Cystoid Macular Edema Business (2016-2021)
11.2.5 Fovea Pharmaceuticals Recent Development
11.3 Icon Bioscience
11.3.1 Icon Bioscience Company Details
11.3.2 Icon Bioscience Business Overview
11.3.3 Icon Bioscience Cystoid Macular Edema Introduction
11.3.4 Icon Bioscience Revenue in Cystoid Macular Edema Business (2016-2021)
11.3.5 Icon Bioscience Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Cystoid Macular Edema Introduction
11.4.4 Merck Revenue in Cystoid Macular Edema Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sanwa Kagaku Kenkyusho
11.5.1 Sanwa Kagaku Kenkyusho Company Details
11.5.2 Sanwa Kagaku Kenkyusho Business Overview
11.5.3 Sanwa Kagaku Kenkyusho Cystoid Macular Edema Introduction
11.5.4 Sanwa Kagaku Kenkyusho Revenue in Cystoid Macular Edema Business (2016-2021)
11.5.5 Sanwa Kagaku Kenkyusho Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Cystoid Macular Edema Introduction
11.6.4 Novartis Revenue in Cystoid Macular Edema Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Johns Hopkins University
11.7.1 Johns Hopkins University Company Details
11.7.2 Johns Hopkins University Business Overview
11.7.3 Johns Hopkins University Cystoid Macular Edema Introduction
11.7.4 Johns Hopkins University Revenue in Cystoid Macular Edema Business (2016-2021)
11.7.5 Johns Hopkins University Recent Development
11.8 Wake Forest University
11.8.1 Wake Forest University Company Details
11.8.2 Wake Forest University Business Overview
11.8.3 Wake Forest University Cystoid Macular Edema Introduction
11.8.4 Wake Forest University Revenue in Cystoid Macular Edema Business (2016-2021)
11.8.5 Wake Forest University Recent Development
11.9 Iladevi Cataract
11.9.1 Iladevi Cataract Company Details
11.9.2 Iladevi Cataract Business Overview
11.9.3 Iladevi Cataract Cystoid Macular Edema Introduction
11.9.4 Iladevi Cataract Revenue in Cystoid Macular Edema Business (2016-2021)
11.9.5 Iladevi Cataract Recent Development
11.10 IOL Research Center
11.10.1 IOL Research Center Company Details
11.10.2 IOL Research Center Business Overview
11.10.3 IOL Research Center Cystoid Macular Edema Introduction
11.10.4 IOL Research Center Revenue in Cystoid Macular Edema Business (2016-2021)
11.10.5 IOL Research Center Recent Development
11.11 Rabin Medical Center
11.11.1 Rabin Medical Center Company Details
11.11.2 Rabin Medical Center Business Overview
11.11.3 Rabin Medical Center Cystoid Macular Edema Introduction
11.11.4 Rabin Medical Center Revenue in Cystoid Macular Edema Business (2016-2021)
11.11.5 Rabin Medical Center Recent Development
11.12 Kyushu University
11.12.1 Kyushu University Company Details
11.12.2 Kyushu University Business Overview
11.12.3 Kyushu University Cystoid Macular Edema Introduction
11.12.4 Kyushu University Revenue in Cystoid Macular Edema Business (2016-2021)
11.12.5 Kyushu University Recent Development
11.13 Wills Eye Institute
11.13.1 Wills Eye Institute Company Details
11.13.2 Wills Eye Institute Business Overview
11.13.3 Wills Eye Institute Cystoid Macular Edema Introduction
11.13.4 Wills Eye Institute Revenue in Cystoid Macular Edema Business (2016-2021)
11.13.5 Wills Eye Institute Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cystoid Macular Edema Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Anti- Vascular Endothelial Growth Factor (VEGF) Agents
Table 4. Key Players of Carbonic Anhydrase Inhibitors
Table 5. Key Players of Steroids
Table 6. Global Cystoid Macular Edema Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cystoid Macular Edema Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cystoid Macular Edema Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cystoid Macular Edema Market Share by Regions (2016-2021)
Table 10. Global Cystoid Macular Edema Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cystoid Macular Edema Market Share by Regions (2022-2027)
Table 12. Cystoid Macular Edema Market Trends
Table 13. Cystoid Macular Edema Market Drivers
Table 14. Cystoid Macular Edema Market Challenges
Table 15. Cystoid Macular Edema Market Restraints
Table 16. Global Cystoid Macular Edema Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cystoid Macular Edema Market Share by Players (2016-2021)
Table 18. Global Top Cystoid Macular Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystoid Macular Edema as of 2020)
Table 19. Ranking of Global Top Cystoid Macular Edema Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cystoid Macular Edema Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cystoid Macular Edema Product Solution and Service
Table 23. Date of Enter into Cystoid Macular Edema Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cystoid Macular Edema Revenue Market Share by Type (2016-2021)
Table 27. Global Cystoid Macular Edema Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cystoid Macular Edema Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cystoid Macular Edema Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cystoid Macular Edema Revenue Market Share by Application (2016-2021)
Table 31. Global Cystoid Macular Edema Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cystoid Macular Edema Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cystoid Macular Edema Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cystoid Macular Edema Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cystoid Macular Edema Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cystoid Macular Edema Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cystoid Macular Edema Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cystoid Macular Edema Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cystoid Macular Edema Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cystoid Macular Edema Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cystoid Macular Edema Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cystoid Macular Edema Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cystoid Macular Edema Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cystoid Macular Edema Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cystoid Macular Edema Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cystoid Macular Edema Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cystoid Macular Edema Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cystoid Macular Edema Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cystoid Macular Edema Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cystoid Macular Edema Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cystoid Macular Edema Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cystoid Macular Edema Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cystoid Macular Edema Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cystoid Macular Edema Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cystoid Macular Edema Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cystoid Macular Edema Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cystoid Macular Edema Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cystoid Macular Edema Market Size by Country (2022-2027) & (US$ Million)
Table 63. EMMES Company Details
Table 64. EMMES Business Overview
Table 65. EMMES Cystoid Macular Edema Product
Table 66. EMMES Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 67. EMMES Recent Development
Table 68. Fovea Pharmaceuticals Company Details
Table 69. Fovea Pharmaceuticals Business Overview
Table 70. Fovea Pharmaceuticals Cystoid Macular Edema Product
Table 71. Fovea Pharmaceuticals Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 72. Fovea Pharmaceuticals Recent Development
Table 73. Icon Bioscience Company Details
Table 74. Icon Bioscience Business Overview
Table 75. Icon Bioscience Cystoid Macular Edema Product
Table 76. Icon Bioscience Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 77. Icon Bioscience Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Cystoid Macular Edema Product
Table 81. Merck Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Sanwa Kagaku Kenkyusho Company Details
Table 84. Sanwa Kagaku Kenkyusho Business Overview
Table 85. Sanwa Kagaku Kenkyusho Cystoid Macular Edema Product
Table 86. Sanwa Kagaku Kenkyusho Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 87. Sanwa Kagaku Kenkyusho Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Cystoid Macular Edema Product
Table 91. Novartis Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Johns Hopkins University Company Details
Table 94. Johns Hopkins University Business Overview
Table 95. Johns Hopkins University Cystoid Macular Edema Product
Table 96. Johns Hopkins University Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 97. Johns Hopkins University Recent Development
Table 98. Wake Forest University Company Details
Table 99. Wake Forest University Business Overview
Table 100. Wake Forest University Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 101. Wake Forest University Recent Development
Table 102. Iladevi Cataract Company Details
Table 103. Iladevi Cataract Business Overview
Table 104. Iladevi Cataract Cystoid Macular Edema Product
Table 105. Iladevi Cataract Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 106. Iladevi Cataract Recent Development
Table 107. IOL Research Center Company Details
Table 108. IOL Research Center Business Overview
Table 109. IOL Research Center Cystoid Macular Edema Product
Table 110. IOL Research Center Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 111. IOL Research Center Recent Development
Table 112. Rabin Medical Center Company Details
Table 113. Rabin Medical Center Business Overview
Table 114. Rabin Medical Center Cystoid Macular Edema Product
Table 115. Rabin Medical Center Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 116. Rabin Medical Center Recent Development
Table 117. Kyushu University Company Details
Table 118. Kyushu University Business Overview
Table 119. Kyushu University Cystoid Macular Edema Product
Table 120. Kyushu University Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 121. Kyushu University Recent Development
Table 122. Wills Eye Institute Company Details
Table 123. Wills Eye Institute Business Overview
Table 124. Wills Eye Institute Cystoid Macular Edema Product
Table 125. Wills Eye Institute Revenue in Cystoid Macular Edema Business (2016-2021) & (US$ Million)
Table 126. Wills Eye Institute Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystoid Macular Edema Market Share by Type: 2020 VS 2027
Figure 2. Non Steroidal Anti-Inflammatory Drugs Features
Figure 3. Anti- Vascular Endothelial Growth Factor (VEGF) Agents Features
Figure 4. Carbonic Anhydrase Inhibitors Features
Figure 5. Steroids Features
Figure 6. Global Cystoid Macular Edema Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Cystoid Macular Edema Report Years Considered
Figure 11. Global Cystoid Macular Edema Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cystoid Macular Edema Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cystoid Macular Edema Market Share by Regions: 2020 VS 2027
Figure 14. Global Cystoid Macular Edema Market Share by Regions (2022-2027)
Figure 15. Global Cystoid Macular Edema Market Share by Players in 2020
Figure 16. Global Top Cystoid Macular Edema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystoid Macular Edema as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cystoid Macular Edema Revenue in 2020
Figure 18. Global Cystoid Macular Edema Revenue Market Share by Type (2016-2021)
Figure 19. Global Cystoid Macular Edema Revenue Market Share by Type (2022-2027)
Figure 20. North America Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cystoid Macular Edema Market Share by Type (2016-2027)
Figure 22. North America Cystoid Macular Edema Market Share by Application (2016-2027)
Figure 23. North America Cystoid Macular Edema Market Share by Country (2016-2027)
Figure 24. United States Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cystoid Macular Edema Market Share by Type (2016-2027)
Figure 28. Europe Cystoid Macular Edema Market Share by Application (2016-2027)
Figure 29. Europe Cystoid Macular Edema Market Share by Country (2016-2027)
Figure 30. Germany Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cystoid Macular Edema Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cystoid Macular Edema Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cystoid Macular Edema Market Share by Region (2016-2027)
Figure 40. China Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cystoid Macular Edema Market Share by Type (2016-2027)
Figure 48. Latin America Cystoid Macular Edema Market Share by Application (2016-2027)
Figure 49. Latin America Cystoid Macular Edema Market Share by Country (2016-2027)
Figure 50. Mexico Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cystoid Macular Edema Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cystoid Macular Edema Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cystoid Macular Edema Market Share by Country (2016-2027)
Figure 56. Turkey Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cystoid Macular Edema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. EMMES Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 60. Fovea Pharmaceuticals Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 61. Icon Bioscience Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 63. Sanwa Kagaku Kenkyusho Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 65. Johns Hopkins University Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 66. Wake Forest University Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 67. Iladevi Cataract Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 68. IOL Research Center Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 69. Rabin Medical Center Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 70. Kyushu University Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 71. Wills Eye Institute Revenue Growth Rate in Cystoid Macular Edema Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
- 世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
- 世界の黄斑浮腫治療市場規模・現状・予測（2021年-2027年） Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…